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Purpose. To evaluate Magnetic Resonance (MR) imaging patterns of differentiation from osteitis to other radiation induced bone
changes, metastasis or tumoral extension, after radiotherapy (RT) of STS.
Materials and methods. Twenty one patients were selected from our data base of sarcomas at Cruces University Hospital, from
March 2004 to December 2010. All of them, STS of extremities, who went through radical surgical resection and radiotherapy.
Image ﬁndings in MR were reviewed to differentiate potential post-treatment changes, and differentiate them, from recurrent
tumor, with clinical correlation. 51.38% of selected patients were female, and 47.62% male. 3 cases of radiation osteitis were
identiﬁed (prevalence of 14.2%). The mean age was 65.6. 2 patients (66.6%) had a myxoid liposarcoma and 1 patient (33.3%)
a high-grade ﬁbrosarcoma. Median dose was 55Gy (range, 45–60Gy). Brachytherapy was used in 1 patient (33.3%). MR shows
changes in the marrow signal within the region of tumor bed, these abnormalities have low intensity in T1 sequences and high
signal in T2 and STIR. After administration of gadolinium, in T1 weighted and SPIR sequences, slight heterogenous enhanced
areas appear, due to ﬁbrotic changes. These signal changes are focal, show geographic distribution, a faint enhancement mainly
in peripheral areas, are not accompanied by soft tissue mass, does not exist in the ﬁrst MR controls, and they increase in size
and number at subsequent follow-up.
Conclusions. MR can illustrate abnormal bone change distribution and is useful for diagnosing osteitis by characteristic inten-
sity patterns. Adding STIR sequence would be considered if radiation osteitis is suspected, in order to improve diagnosis from
recurrent disease, follow-up and treatment if required, in these patients.
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Background and purpose. Bulbar and pseudobulbar palsy is deﬁned by impairment of cranial nerves due to lower and upper
motor neuron lesions. Amyotrophic lateral sclerosis and Parkinson’s disease are examples of this kind of neurological pathology.
Sialorrhea is a frequent symptom, because of progressive weakness of oral, lingual and pharyngeal muscles. As salivary glands
radiation provokes xerostomia, this study aims to investigate the response to palliative radiotherapy parotid, to reduce salivary
secretion in these patients.
Materials and methods. We report data from ﬁfteen patients treated between March 2010 and January 2012 (nine women and
six men), mean aged 56.6 years (range from 29 to 84). Thirteen were diagnosed with amyotrophic lateral sclerosis and two
with Parkinson’s disease with major drooling problems. Therapy with anticholinergics and intraparotid botulinum toxin had
failed in most of them. All the patients were treated with palliative external radiation therapy to reduce salivary secretion.
Conformal radiotherapy technique with two oblique anterior and posterior wedged ﬁelds was chosen. In ten patients, 8Gy dose
was prescribed to the isocentre using 6MV photons in a single fraction. Five patients received two 8Gy dose fractions in each of
the parotid glands, for a period of two months after the ﬁrst fraction. As majority of patients had decubitus intolerance, adequate
immobilization systems were possible only in some of them. We analyze the treatment toxicity.
Results. After radiotherapy, nine patients had a signiﬁcant reduction of salivary secretion. Four patients did not achieve a relevant
reduction of sialorrhea or any subjective improvement. The last two patients were lost or died in this period as a result of the
underlying disease. All of them had cutaneous transient toxicity as the only side effect.
Conclusions. In the present study we show a signiﬁcative improvement of sialorrhea in patients with bulbar and pseudobulbar
palsy, after single or twice fraction of external palliative radiation therapy when other treatments have failed. No major side
effects appeared, apart from radiation-induced dermatitis.
http://dx.doi.org/10.1016/j.rpor.2013.03.393
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Introduction. Radiotherapy can prevent progression of early-stage Dupuytren’s contracture. To report our experience and make a
review of the literature.
Methods. Between 2011 and 2012, 5 patients have been treated in our Hospital with electrons (5MeV). We use individual lead and
we treat the diseased areas only. According to Tubiana’s classiﬁcation, 3 patients had stage N/I, 1 had stage I and 1 had stage
II. We have evaluated subjective response, objective response (palpable nodules and cords, functional changes) and acute and
chronic toxicity.
Results. All patients received 5×3Gy (total dose 21Gy). The mean age was 57 years. 80% were men. 4 patients had been treated
before radiotherapy, with local excision (75%). With a follow-up of 11 months, 60% patients observed subjective response and 20%
patients observed stable situation. Objective reduction of nodules and cords occurred in 3 patients, 1 of them had also functional
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improvement. 1 patient progressed and have required salvage treatment. None of them have presented nor acute toxicity neither
chronic toxicity.
Conclusion. Radiotherapy prevents disease progression for early-stage Dupuytren’s contracture. This way we can avoid new
surgical procedures.
http://dx.doi.org/10.1016/j.rpor.2013.03.394
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Introduction. Ledderhose’s disease or plantar ﬁbromatosis is a proliferative disorder affecting connective tissue of the plantar fas-
cia, it is very similar to Dupuytren’s disease that affects the hands. It is characterized by the appearance of painful subcutaneous
ﬁbrous nodules that may difﬁcult the walk. Treatments include corticoids and surgery with disappointing results. The rate of
recurrence after surgery is high 30–50%. There are not many references in the literature1,2 about irradiation treatment of this
disease. It is not established dose or regimes of treatment at the present. Objectives: To report our experience with ﬁve patients
treated with irradiation.
Methods. Between September 2011 and September 2012 ﬁve patients with Ledderhose’s disease were referred to our department.
They were treated with direct electron ﬁeld with a total dose of 30Gy, 3Gy fraction.
Results. The mean age was 44.5 years (30–53 years), three women and two men. There has been no progression after treatment.
Responses were obtained in the two males, one complete remission and 90% response respectively, with complete disappearance
of pain (40%). In the remaining three patients stable disease without clinical improvement (60%) were observed. There has been
no acute or late toxicity.
Conclusions. Although the follow up and number of patients are small, the observed results are similar to published series in the
literature (24 and 25 patients respectively). Radiotherapy is an effective treatment, and complete remission can be obtained for
both pain and the tumor.
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Introduction. Castleman disease (CD) is a rare benign disorder characterised by hyperplasia of lymphoid tissue that may develop at
a single site (unicentric) or throughout the body (multicentric). It involves hyperproliferation of certain B cells that often produce
cytokine IL-6. Surgery remains themain treatment for resectable unicentric CD, since removal of the largenode is possiblewithout
further complications. No consensus has been reached concerning the most adequate treatment for irresectable unicentric CD.
Objective. Case report description of a unresectable unicentric CD with a successful response after radiotherapy.
Methods. The patient was a 24-year-old man with a nephrotic syndrome becasue of mesangial proliferative glomerulonephritis.
FDG-PET/CT found a right hiliar mass of 3.5 cm of diameter. Open thoracotomy showed inﬁltration of the right pulmonary artery
and superior pulmonary vein requiring a neumonectomy. Histopathological analysis of the tumor showed hyaline vascular type
of CD. The patient was transferred to our department. Radiotherapy treatment was performed with 3DRT (6Mv) giving 46Gy
(200 cGy/fraction).
Results. CT showed a progressive reduction of the mass at 3 and 6 months, with complete remission at 12 months. Patient was
asymptomatic without late effects and without nephrotic syndrome.
Conclusion. Radiotherapy should be considered in case of an unresectable unicentric CD.
http://dx.doi.org/10.1016/j.rpor.2013.03.396
